Austin, TX — ATX Clinical Trials Inc. dba Keystone Research has secured $2,805,000.00 in new commercial financing for expansion opportunities in Austin. According to the company website, Keystone Research is an international leader in ophthalmic clinical trials dedicated to bridging the ophthalmic industry with FDA-approved, sight saving innovations.

To learn more about ATX Clinical Trials Inc. dba Keystone Research please visit: http://www.keystoneresearch.com/

Company Contact:
Trisha Locke, Chief Executive Officer
512-451-4400
https://www.linkedin.com/in/trishalockeatx/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved